ACE 536 B THAL 001 A PHASE 3 DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED MULTICENTER STUDY TO DETERMINE THE EFFICACY AND SAFETY OF LUSPATERCEPT ACE 536 VERSUS PLACEBO IN ADULTS WHO REQUIRE REGULAR RED BLOOD CELL TRANSFUSIONS DUE TO BETA b THALASSEMIA